Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)

SHE:300683 Statistics

Total Valuation

SHE:300683 has a market cap or net worth of CNY 4.62 billion. The enterprise value is 4.26 billion.

Market Cap	4.62B
Enterprise Value	4.26B

Important Dates

The last earnings date was Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

SHE:300683 has 130.89 million shares outstanding. The number of shares has increased by 0.24% in one year.

Current Share Class	130.89M
Shares Outstanding	130.89M
Shares Change (YoY)	+0.24%
Shares Change (QoQ)	-2.02%
Owned by Insiders (%)	11.15%
Owned by Institutions (%)	0.28%
Float	72.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.50
PB Ratio	2.15
P/TBV Ratio	2.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.72
EV / Sales	7.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-54.45

Financial Position

The company has a current ratio of 4.17, with a Debt / Equity ratio of 0.03.

Current Ratio	4.17
Quick Ratio	2.58
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.71
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -10.78% and return on invested capital (ROIC) is -7.75%.

Return on Equity (ROE)	-10.78%
Return on Assets (ROA)	-2.89%
Return on Invested Capital (ROIC)	-7.75%
Return on Capital Employed (ROCE)	-5.52%
Weighted Average Cost of Capital (WACC)	4.23%
Revenue Per Employee	415,451
Profits Per Employee	-183,638
Employee Count	1,309
Asset Turnover	0.20
Inventory Turnover	3.40

Taxes

Income Tax	-4.83M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.37% in the last 52 weeks. The beta is 0.01, so SHE:300683's price volatility has been lower than the market average.

Beta (5Y)	0.01
52-Week Price Change	+60.37%
50-Day Moving Average	35.70
200-Day Moving Average	36.05
Relative Strength Index (RSI)	48.31
Average Volume (20 Days)	13,627,994

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300683 had revenue of CNY 543.82 million and -240.38 million in losses. Loss per share was -1.83.

Revenue	543.82M
Gross Profit	222.52M
Operating Income	-124.03M
Pretax Income	-249.77M
Net Income	-240.38M
EBITDA	-28.54M
EBIT	-124.03M
Loss Per Share	-1.83

Balance Sheet

The company has 423.52 million in cash and 55.67 million in debt, with a net cash position of 367.85 million or 2.81 per share.

Cash & Cash Equivalents	423.52M
Total Debt	55.67M
Net Cash	367.85M
Net Cash Per Share	2.81
Equity (Book Value)	2.15B
Book Value Per Share	16.70
Working Capital	940.84M

Cash Flow

In the last 12 months, operating cash flow was -29.26 million and capital expenditures -48.99 million, giving a free cash flow of -78.25 million.

Operating Cash Flow	-29.26M
Capital Expenditures	-48.99M
Depreciation & Amortization	95.49M
Net Borrowing	-3.67M
Free Cash Flow	-78.25M
FCF Per Share	-0.60

Margins

Gross margin is 40.92%, with operating and profit margins of -22.81% and -44.20%.

Gross Margin	40.92%
Operating Margin	-22.81%
Pretax Margin	-45.93%
Profit Margin	-44.20%
EBITDA Margin	-5.25%
EBIT Margin	-22.81%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.37%.

Dividend Per Share	0.13
Dividend Yield	0.37%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.24%
Shareholder Yield	0.12%
Earnings Yield	-5.20%
FCF Yield	-1.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1